Are you ready for tires with pink sidewalls?

Omni United, one of the fastest growing designers and manufacturers of tires, has announced Radar's plans to launch a limited-edition pink walled tire in support of 'Mobilizing Hope' – the flagship brand's groundbreaking year-long partnership with The Breast Cancer Research Foundation (BCRF).

As part of the Mobilizing Hope campaign, launched in the United States and other markets during May 2011, Radar will donate 25¢ from every Radar tire sold, with a minimum annual donation commitment of $250,000 to BCRF.

Radar's first product specifically designed to support this campaign will be a limited edition of its RPX900 tire, an all season, high performance, eco-friendly tire featuring an asymmetrical tread design that is ideal for mid to high performance vehicles.

The Limited Edition has the novelty of a pink sidewall, highlighting the emblematic pink color of the fight against breast cancer cause globally. The tire will have a retail price in the range from $70 to $110 and will be available starting during the last quarter of 2011 at leading Radar tire retailers in the US.

"This is a more visible way to support our Mobilizing Hope campaign to benefit the activities of BCRF," said Mr. G.S. Sareen, President and CEO of Omni United, parent company of Radar Tires. "We are delighted to be able to develop this limited edition of one of our best selling tires, the RPX900, to reinforce our commitment to supporting breast cancer research."

About Omni / Radar
Radar Tires is the flagship tire brand of Omni United, offering a complete range of passenger car, SUV, truck, bus, and farm tires, marketed under four brand names: Radar, Goodride, Roadlux and Corsa. Besides designing and manufacturing tires, Omni's excellent customer service and state-of-the-art logistics and supply management systems are a cornerstone to their success.

About The Breast Cancer Research Foundation
The BCRF was founded in1993 by Evelyn H. Lauder as an independent, not-for-profit organization dedicated to funding innovative clinical and translational research at leading medical centers worldwide. In October 2010, BCRF awarded $33 million to 172 scientists across the United States, Canada, Latin America, Europe, the Middle East and Australia. Currently, more than 90 cents of every dollar donated is directed to breast cancer research and awareness programs.